A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)

Clinical trial NCT04846920 · COMPLETED

Trial details

NCT number: NCT04846920
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2021-06-14
Primary completion: 2026-04-11
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.